RDHL - レッドヒル・バイオファ―マ （Redhill Biopharma Ltd.） レッドヒル・バイオファ―マRDHLのチャート
RDHLの企業情報
| symbol | RDHL |
|---|---|
| 会社名 | Redhill Biopharma Ltd Ramat Gan （レッドヒル・バイオファ―マ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- レッドヒル・バイオファ―マは、イスラエルのバイオ製薬会社。胃腸癌を含む炎症性および胃腸疾患の治療用に、後期の臨床段階にある独自の経口投与薬剤を開発、買収に注力する。イスラエル、米国、カナダ、欧州で事業を展開。同社の製品パイプラインは、後期の臨床段階にある8薬の治療候補で構成される。 RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults, Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults, and Aemcolo® for the treatment of travelers' diarrhea in adults. RedHill's key clinical late-stage development programs include: (i) RHB-204, with an ongoing Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) disease; (ii) opaganib (Yeliva®, ABC294640), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; (iii) RHB-107 (upamostat), a serine protease inhibitor in a U.S. Phase 2/3 study as treatment for symptomatic COVID-19, and targeting multiple other cancer and inflammatory gastrointestinal diseases; (iv) RHB-104, with positive results from a first Phase 3 study for Crohn's disease; (v) RHB-102 (Bekinda®), with positive results from a Phase 3 study for acute gastroenteritis and gastritis and positive results from a Phase 2 study for IBS-D; and (vi) RHB-106, an encapsulated bowel preparation. |
| 本社所在地 | 21 Ha'arba'a Street Tel-Aviv 64739 ISR |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 40026 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 74人 |
| url | www.redhillbio.com |
| nasdaq_url | https://www.nasdaq.com/symbol/rdhl |
| adr_tso | 15297124 |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 8.38 |
| 時価総額（marketcap） | 128189899.12 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
RDHLのテクニカル分析
RDHLのニュース
RedHill Biopharma jumps 4% on regaining compliance with Nasdaq 2023/04/11 11:17:29 Seeking Alpha
Nasdaq notifies RedHill Biopharma (RDHL) on regaining compliance with the minimum bid price requirementThe company maintained a minimum closing bid price of $1.00 or more for at least…
RedHill Biopharma Announces Closing of $6 Million Registered Direct Offering 2023/04/03 17:26:00 PR Newswire
TEL AVIV, Israel and RALEIGH, N.C., April 3, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed its previously announced registered direct offering for the purchase and sale of…
RedHill Biopharma to raise $6M in ADSs offering 2023/03/30 12:20:35 Seeking Alpha
RedHill Biopharma (RDHL) entered into a definitive agreement for the purchase and sale of 1.5M ADSs; each ADS represents 400 ordinary shares, series A warrants to purchase up to 1.5M…
RedHill Biopharma Announces $6 Million Registered Direct Offering 2023/03/30 12:00:00 PR Newswire
TEL AVIV, Israel and RALEIGH, N.C., March 30, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of 1,500,000 of the…
RedHill Biopharma to Implement ADS Ratio Change to 1:400 2023/03/17 09:51:04 Investing.com
https://www.investing.com/news/assorted/redhill-biopharma-to-implement-ads-ratio-change-to-1400-432SI-3033170
RedHill Biopharma Announces Closing of $6 Million Registered Direct Offering 2023/04/03 17:26:00 PR Newswire
TEL AVIV, Israel and RALEIGH, N.C., April 3, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed its previously announced registered direct offering for the purchase and sale of…
RedHill Biopharma to raise $6M in ADSs offering 2023/03/30 12:20:35 Seeking Alpha
RedHill Biopharma (RDHL) entered into a definitive agreement for the purchase and sale of 1.5M ADSs; each ADS represents 400 ordinary shares, series A warrants to purchase up to 1.5M…
RedHill Biopharma Announces $6 Million Registered Direct Offering 2023/03/30 12:00:00 PR Newswire
TEL AVIV, Israel and RALEIGH, N.C., March 30, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of 1,500,000 of the…
RedHill Biopharma to Implement ADS Ratio Change to 1:400 2023/03/17 09:51:04 Investing.com
https://www.investing.com/news/assorted/redhill-biopharma-to-implement-ads-ratio-change-to-1400-432SI-3033170
RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor 2023/03/09 00:05:00 PR Newswire
TEL AVIV, Israel and RALEIGH, NC, March 8, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreement, with a single investor, for the issuance of convertible promissory note in the principal…
RedHill Biopharma to be issued U.S. patent related to fixed-dose products 2023/02/27 21:05:02 Investing.com
https://www.investing.com/news/pro/redhill-biopharma-to-be-issued-us-patent-related-to-fixeddose-products-432SI-3016054
Morning Traders Alert: SHF Holdings, Inc. (NASDAQ:SHFS), RedHill Biopharma Ltd. (NASDAQ:RDHL) 2023/02/27 17:00:09 Stock Equity
SHFS has seen its SMA50 which is now -42.44%. In looking the SMA 200 we see that the stock has seen a -88.36%. RDHL has seen its SMA50 which is … The post Morning Traders Alert: SHF Holdings, Inc. (NASDAQ:SHFS), RedHill Biopharma Ltd. (NASDAQ:RDHL) appeared first on Stocks Equity .
Current Volume Sizzlers: Aurora Cannabis Inc. (NASDAQ:ACB), RedHill Biopharma Ltd. (NASDAQ:RDHL) 2023/02/24 18:16:17 Stock Equity
ACB has seen its SMA50 which is now -12.22%. In looking the SMA 200 we see that the stock has seen a -38.48%. RDHL has seen its SMA50 which is … The post Current Volume Sizzlers: Aurora Cannabis Inc. (NASDAQ:ACB), RedHill Biopharma Ltd. (NASDAQ:RDHL) appeared first on Stocks Equity .
Current Stocks’s Volume Buzz: RedHill Biopharma Ltd. (NASDAQ:RDHL), Oak Street Health, Inc. (NYSE:OSH) 2023/02/22 17:14:15 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Stocks’s Volume Buzz: RedHill Biopharma Ltd. (NASDAQ:RDHL), Oak Street Health, Inc. (NYSE:OSH) appeared first on Stocks Equity .
Morning Traders Recap: RedHill Biopharma Ltd. (NASDAQ:RDHL -2.14%), NexImmune, Inc. (NASDAQ:NEXI -9.88%) 2023/02/21 16:50:28 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Traders Recap: RedHill Biopharma Ltd. (NASDAQ:RDHL -2.14%), NexImmune, Inc. (NASDAQ:NEXI -9.88%) appeared first on Stocks Equity .